Your browser doesn't support javascript.
loading
Persistent or Transient Human ß Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes.
Marselli, Lorella; Piron, Anthony; Suleiman, Mara; Colli, Maikel L; Yi, Xiaoyan; Khamis, Amna; Carrat, Gaelle R; Rutter, Guy A; Bugliani, Marco; Giusti, Laura; Ronci, Maurizio; Ibberson, Mark; Turatsinze, Jean-Valery; Boggi, Ugo; De Simone, Paolo; De Tata, Vincenzo; Lopes, Miguel; Nasteska, Daniela; De Luca, Carmela; Tesi, Marta; Bosi, Emanuele; Singh, Pratibha; Campani, Daniela; Schulte, Anke M; Solimena, Michele; Hecht, Peter; Rady, Brian; Bakaj, Ivona; Pocai, Alessandro; Norquay, Lisa; Thorens, Bernard; Canouil, Mickaël; Froguel, Philippe; Eizirik, Decio L; Cnop, Miriam; Marchetti, Piero.
Afiliação
  • Marselli L; Department of Clinical and Experimental Medicine, and AOUP Cisanello University Hospital, University of Pisa, Pisa 56126, Italy. Electronic address: lorella.marselli@med.unipi.it.
  • Piron A; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium.
  • Suleiman M; Department of Clinical and Experimental Medicine, and AOUP Cisanello University Hospital, University of Pisa, Pisa 56126, Italy.
  • Colli ML; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium.
  • Yi X; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium.
  • Khamis A; INSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, Lille University Hospital, Lille 59000, France.
  • Carrat GR; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology, and Metabolism, Imperial College, London, UK.
  • Rutter GA; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology, and Metabolism, Imperial College, London, UK; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Bugliani M; Department of Clinical and Experimental Medicine, and AOUP Cisanello University Hospital, University of Pisa, Pisa 56126, Italy.
  • Giusti L; Department of Clinical and Experimental Medicine, and AOUP Cisanello University Hospital, University of Pisa, Pisa 56126, Italy; School of Pharmacy, University of Camerino, Camerino, Italy.
  • Ronci M; Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy; Centre for Advanced Studies and Technologies (CAST), University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
  • Ibberson M; Vital-IT Group, Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland.
  • Turatsinze JV; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium.
  • Boggi U; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy; Division of General and Transplant Surgery, Cisanello University Hospital, Pisa 56124, Italy.
  • De Simone P; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy; Division of Liver Surgery and Transplantation, Cisanello University Hospital, Pisa 56124, Italy.
  • De Tata V; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy.
  • Lopes M; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium.
  • Nasteska D; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium.
  • De Luca C; Department of Clinical and Experimental Medicine, and AOUP Cisanello University Hospital, University of Pisa, Pisa 56126, Italy.
  • Tesi M; Department of Clinical and Experimental Medicine, and AOUP Cisanello University Hospital, University of Pisa, Pisa 56126, Italy.
  • Bosi E; Department of Clinical and Experimental Medicine, and AOUP Cisanello University Hospital, University of Pisa, Pisa 56126, Italy.
  • Singh P; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium.
  • Campani D; Department of Surgical, Medical and Molecular Pathology and the Critical Areas, University of Pisa, Pisa 56126, Italy.
  • Schulte AM; Sanofi-Aventis Deutschland GmbH, Diabetes Research, Frankfurt, Germany.
  • Solimena M; Paul Langerhans Institute Dresden of the Helmholtz Center Munich at University Hospital Carl Gustav Carus and Faculty of Medicine, TU Dresden, Dresden 01307, Germany; German Center for Diabetes Research (DZD e.V.), Neuherberg 85764, Germany.
  • Hecht P; Sanofi-Aventis Deutschland GmbH, Diabetes Research, Frankfurt, Germany.
  • Rady B; Janssen RDUS, Philadelphia, PA, USA.
  • Bakaj I; Janssen RDUS, Philadelphia, PA, USA.
  • Pocai A; Janssen RDUS, Philadelphia, PA, USA.
  • Norquay L; Janssen RDUS, Philadelphia, PA, USA.
  • Thorens B; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
  • Canouil M; INSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, Lille University Hospital, Lille 59000, France.
  • Froguel P; Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, UK.
  • Eizirik DL; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium; WELBIO, Université Libre de Bruxelles, Brussels, Belgium; Indiana Biosciences Research Institute, Indianapolis, IN, USA; Division of Endocrinology, ULB Erasmus Hospital, Université Libre de Bruxelles, Brussels,
  • Cnop M; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels 1070, Belgium; Division of Endocrinology, ULB Erasmus Hospital, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: mcnop@ulb.ac.be.
  • Marchetti P; Department of Clinical and Experimental Medicine, and AOUP Cisanello University Hospital, University of Pisa, Pisa 56126, Italy. Electronic address: piero.marchetti@med.unipi.it.
Cell Rep ; 33(9): 108466, 2020 12 01.
Article em En | MEDLINE | ID: mdl-33264613
ABSTRACT
Pancreatic ß cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whether human ß cell dysfunction induced by metabolic stress is reversible, evaluate the molecular pathways underlying persistent or transient damage, and explore the relationships with T2D islet traits. Twenty-six islet preparations are exposed to several lipotoxic/glucotoxic conditions, some of which impair insulin release, depending on stressor type, concentration, and combination. The reversal of dysfunction occurs after washout for some, although not all, of the lipoglucotoxic insults. Islet transcriptomes assessed by RNA sequencing and expression quantitative trait loci (eQTL) analysis identify specific pathways underlying ß cell failure and recovery. Comparison of a large number of human T2D islet transcriptomes with those of persistent or reversible ß cell lipoglucotoxicity show shared gene expression signatures. The identification of mechanisms associated with human ß cell dysfunction and recovery and their overlap with T2D islet traits provide insights into T2D pathogenesis, fostering the development of improved ß cell-targeted therapeutic strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estresse Fisiológico / Expressão Gênica / Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estresse Fisiológico / Expressão Gênica / Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2020 Tipo de documento: Article